These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2526762

  • 1. Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats.
    Okabayashi Y, Otsuki M, Ohki A, Tani S, Baba S.
    Diabetes; 1989 Aug; 38(8):1042-7. PubMed ID: 2526762
    [Abstract] [Full Text] [Related]

  • 2. A comparison between insulin and glucagon release from orthotopically-placed islets of Langerhans and after their transplantation into the liver of diabetic rats.
    Blech W, Brömme HJ, Kohnert KD, Blume R, Hildebrandt W, Hahn HJ.
    Exp Clin Endocrinol; 1989 May; 93(2-3):261-6. PubMed ID: 2528472
    [Abstract] [Full Text] [Related]

  • 3. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.
    Otsuki M, Sakamoto C, Yuu H, Maeda M, Morita S, Ohki A, Kobayashi N, Terashi K, Okano K, Baba S.
    J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241
    [Abstract] [Full Text] [Related]

  • 4. Unresponsiveness to glucose in a streptozocin model of diabetes. Inappropriate insulin and glucagon responses to a reduction of glucose concentration.
    Leahy JL, Weir GC.
    Diabetes; 1985 Jul; 34(7):653-9. PubMed ID: 2861128
    [Abstract] [Full Text] [Related]

  • 5. Glucose- and arginine-induced insulin and glucagon responses from the isolated perfused pancreas of the BB-Wistar diabetic rat. Evidence for selective impairment of glucose regulation.
    Grill V, Herberg L.
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):561-6. PubMed ID: 6342326
    [Abstract] [Full Text] [Related]

  • 6. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
    Grill V, Rundfeldt M.
    Diabetes; 1986 Jan; 35(1):44-51. PubMed ID: 2416619
    [Abstract] [Full Text] [Related]

  • 7. Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats.
    Ostenson CG, Efendic S, Grill V.
    Pancreas; 1990 May; 5(3):347-53. PubMed ID: 1971441
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
    Kawai K, Suzuki S, Murayama Y, Watanabe Y, Yamashita K.
    Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
    [Abstract] [Full Text] [Related]

  • 13. Pancreatic hormones in streptozotocin-diabetic rats.
    Tomita T, Sasaki S, Doull V, Bunag R, Kimmel JR.
    Int J Pancreatol; 1986 Oct; 1(3-4):265-78. PubMed ID: 2890693
    [Abstract] [Full Text] [Related]

  • 14. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
    Inoue K, Hisatomi A, Umeda F, Nawata H.
    Diabetes; 1992 Jun; 41(6):723-7. PubMed ID: 1534057
    [Abstract] [Full Text] [Related]

  • 15. Insulin and glucose as modulators of the amino acid-induced glucagon release in the isolated pancreas of alloxan and streptozotocin diabetic rats.
    Pagliara AS, Stillings SN, Haymond MW, Hover BA, Matschinsky FM.
    J Clin Invest; 1975 Feb; 55(2):244-55. PubMed ID: 123928
    [Abstract] [Full Text] [Related]

  • 16. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P, Bailbé D, Portha B.
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [Abstract] [Full Text] [Related]

  • 17. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
    Tachibana I, Akiyama T, Kanagawa K, Shiohara H, Furumi K, Watanabe N, Otsuki M.
    Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
    [Abstract] [Full Text] [Related]

  • 18. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
    Suzuki S, Kawai K, Ohashi S, Mukai H, Murayama Y, Yamashita K.
    Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.